Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

Similar articles for PubMed (Select 22592018)

1.

Verbal learning in Alzheimer's disease and mild cognitive impairment: fine-grained acquisition and short-delay consolidation performance and neural correlates.

Genon S, Collette F, Moulin CJ, Lekeu F, Bahri MA, Salmon E, Bastin C.

Neurobiol Aging. 2013 Feb;34(2):361-73. doi: 10.1016/j.neurobiolaging.2012.04.004. Epub 2012 May 15.

PMID:
22592018
2.

Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease.

Kadir A, Almkvist O, Forsberg A, Wall A, Engler H, Långström B, Nordberg A.

Neurobiol Aging. 2012 Jan;33(1):198.e1-14. doi: 10.1016/j.neurobiolaging.2010.06.015. Epub 2010 Aug 4.

PMID:
20688420
3.

A two-year follow-up of cognitive deficits and brain perfusion in mild cognitive impairment and mild Alzheimer's disease.

Alegret M, Cuberas-Borrós G, Vinyes-Junqué G, Espinosa A, Valero S, Hernández I, Roca I, Ruíz A, Rosende-Roca M, Mauleón A, Becker JT, Castell-Conesa J, Tárraga L, Boada M.

J Alzheimers Dis. 2012;30(1):109-20. doi: 10.3233/JAD-2012-111850.

4.

Cognitive decline and amyloid accumulation in patients with mild cognitive impairment.

Koivunen J, Karrasch M, Scheinin NM, Aalto S, Vahlberg T, Någren K, Helin S, Viitanen M, Rinne JO.

Dement Geriatr Cogn Disord. 2012;34(1):31-7. doi: 10.1159/000341580. Epub 2012 Aug 3.

PMID:
22868352
5.

Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG.

Carter SF, Schöll M, Almkvist O, Wall A, Engler H, Långström B, Nordberg A.

J Nucl Med. 2012 Jan;53(1):37-46. doi: 10.2967/jnumed.110.087031.

6.

Comparison between the story recall test and the word-list learning test in Korean patients with mild cognitive impairment and early stage of Alzheimer's disease.

Baek MJ, Kim HJ, Kim S.

J Clin Exp Neuropsychol. 2012;34(4):396-404. doi: 10.1080/13803395.2011.645020. Epub 2012 Jan 23.

PMID:
22263656
7.

The National Institute on Aging-Alzheimer's Association research criteria for mild cognitive impairment due to Alzheimer's disease: predicting the outcome.

Guo LH, Alexopoulos P, Eisele T, Wagenpfeil S, Kurz A, Perneczky R.

Eur Arch Psychiatry Clin Neurosci. 2013 Jun;263(4):325-33. doi: 10.1007/s00406-012-0349-0. Epub 2012 Aug 30.

PMID:
22932720
8.

Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.

Villain N, Chételat G, Grassiot B, Bourgeat P, Jones G, Ellis KA, Ames D, Martins RN, Eustache F, Salvado O, Masters CL, Rowe CC, Villemagne VL; AIBL Research Group.

Brain. 2012 Jul;135(Pt 7):2126-39. doi: 10.1093/brain/aws125. Epub 2012 May 23.

9.

Combination of 18F-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer's disease in mild cognitive impairment patients.

Choo IH, Ni R, Schöll M, Wall A, Almkvist O, Nordberg A.

J Alzheimers Dis. 2013;33(4):929-39. doi: 10.3233/JAD-2012-121489.

PMID:
23047371
10.

Increased basal forebrain metabolism in mild cognitive impairment: an evidence for brain reserve in incipient dementia.

Kim MJ, Lee KM, Son YD, Jeon HA, Kim YB, Cho ZH.

J Alzheimers Dis. 2012;32(4):927-38. doi: 10.3233/JAD-2012-120133.

PMID:
22903128
11.

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.

Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, Schwaiger M, Kurz A.

Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1104-13. Epub 2003 May 23.

PMID:
12764551
12.

Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.

Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, Långström B, Nordberg A.

Brain. 2006 Nov;129(Pt 11):2856-66. Epub 2006 Jul 19.

13.

Dissociation between brain amyloid deposition and metabolism in early mild cognitive impairment.

Wu L, Rowley J, Mohades S, Leuzy A, Dauar MT, Shin M, Fonov V, Jia J, Gauthier S, Rosa-Neto P; Alzheimer’s Disease Neuroimaging Initiative.

PLoS One. 2012;7(10):e47905. doi: 10.1371/journal.pone.0047905. Epub 2012 Oct 24.

14.

Relationship between nicotinic receptors and cognitive function in early Alzheimer's disease: a 2-[18F]fluoro-A-85380 PET study.

Ellis JR, Villemagne VL, Nathan PJ, Mulligan RS, Gong SJ, Chan JG, Sachinidis J, O'Keefe GJ, Pathmaraj K, Wesnes KA, Savage G, Rowe CC.

Neurobiol Learn Mem. 2008 Sep;90(2):404-12. doi: 10.1016/j.nlm.2008.05.006. Epub 2008 Jul 11.

PMID:
18620875
15.

Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study.

Nobili F, Frisoni GB, Portet F, Verhey F, Rodriguez G, Caroli A, Touchon J, Calvini P, Morbelli S, De Carli F, Guerra UP, Van de Pol LA, Visser PJ.

J Neurol. 2008 Sep;255(9):1344-53. doi: 10.1007/s00415-008-0897-4. Epub 2008 Aug 1.

PMID:
18958573
16.

A modified method of 3D-SSP analysis for amyloid PET imaging using [¹¹C]BF-227.

Kaneta T, Okamura N, Minoshima S, Furukawa K, Tashiro M, Furumoto S, Iwata R, Fukuda H, Takahashi S, Yanai K, Kudo Y, Arai H.

Ann Nucl Med. 2011 Dec;25(10):732-9. doi: 10.1007/s12149-011-0518-7. Epub 2011 Jul 27.

PMID:
21792587
17.

A visual [18F]FDG-PET rating scale for the differential diagnosis of frontotemporal lobar degeneration.

Poljansky S, Ibach B, Hirschberger B, Männer P, Klünemann H, Hajak G, Marienhagen J.

Eur Arch Psychiatry Clin Neurosci. 2011 Sep;261(6):433-46. doi: 10.1007/s00406-010-0184-0. Epub 2011 Jan 5.

PMID:
21207049
18.

Individual cerebral metabolic deficits in Alzheimer's disease and amnestic mild cognitive impairment: an FDG PET study.

Del Sole A, Clerici F, Chiti A, Lecchi M, Mariani C, Maggiore L, Mosconi L, Lucignani G.

Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1357-66. doi: 10.1007/s00259-008-0773-6. Epub 2008 Apr 17.

PMID:
18418593
19.

Effects of a 6-month cognitive intervention on brain metabolism in patients with amnestic MCI and mild Alzheimer's disease.

Förster S, Buschert VC, Teipel SJ, Friese U, Buchholz HG, Drzezga A, Hampel H, Bartenstein P, Buerger K.

J Alzheimers Dis. 2011;26 Suppl 3:337-48. doi: 10.3233/JAD-2011-0025.

PMID:
21971473
20.

Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease.

Fleisher AS, Chen K, Liu X, Roontiva A, Thiyyagura P, Ayutyanont N, Joshi AD, Clark CM, Mintun MA, Pontecorvo MJ, Doraiswamy PM, Johnson KA, Skovronsky DM, Reiman EM.

Arch Neurol. 2011 Nov;68(11):1404-11. doi: 10.1001/archneurol.2011.150. Epub 2011 Jul 11.

PMID:
21747008
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk